Log in to save to my catalogue

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1528335391

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

About this item

Full title

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2014-05, Vol.370 (21), p.1983-1992

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Among previously untreated patients with HCV genotype 1 infection, three new antiviral agents, with or without ribavirin, resulted in high rates of sustained virologic response. Omission of ribavirin resulted in reduced response in genotype 1a infection but not in genotype 1b infection.
Hepatitis C virus (HCV) infection is a worldwide health iss...

Alternative Titles

Full title

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1528335391

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1528335391

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1402338

How to access this item